205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-21.08%
Both yoy net incomes decline, with AVGO at -6.77%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
2.47%
D&A growth well above AVGO's 0.31%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
55.77%
Lower deferred tax growth vs. AVGO's 1000.00%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
-8.70%
Negative yoy SBC while AVGO is 0.63%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
104.98%
Well above AVGO's 46.21% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
1211.76%
AR growth while AVGO is negative at -19.08%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-288.46%
Negative yoy inventory while AVGO is 384.21%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-125.49%
Negative yoy AP while AVGO is 168.29%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
13.87%
Lower 'other working capital' growth vs. AVGO's 150.00%. David Dodd would see fewer unexpected short-term demands on cash.
1150.00%
Well above AVGO's 938.46%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
1.85%
Operating cash flow growth below 50% of AVGO's 17.27%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
12.70%
CapEx growth well above AVGO's 11.67%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-12.70%
Both yoy lines negative, with AVGO at -128.57%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
89.25%
Less growth in investment purchases vs. AVGO's 200.00%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
26.12%
We have some liquidation growth while AVGO is negative at -638.89%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
15.36%
We have some outflow growth while AVGO is negative at -97.30%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
185.12%
Investing outflow well above AVGO's 32.18%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-30.91%
Both yoy lines negative, with AVGO at -67.80%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-67.42%
We cut yoy buybacks while AVGO is 71.67%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.